S-1: 1847 Holdings Files for Resale of 480 Million Common Shares by Selling Shareholders

1847 Holdings has filed a registration statement for the potential resale of approximately 480 million common shares by its selling shareholders, primarily related to shares and warrants issued in a recent private placement.

Summary

• 1847 Holdings LLC has filed a Form S-1 registration statement with the SEC to register the resale of 480,231,190 common shares.
• These shares are to be offered by selling shareholders and include 3,437,210 common shares already issued, 38,873,908 shares issuable upon exercise of pre-funded warrants, 285,600,046 shares issuable upon exercise of Series A warrants, and 152,320,026 shares issuable upon exercise of Series B warrants.
• The company will not receive any proceeds from the sale of common shares by the selling shareholders or from the exercise of the pre-funded warrants or Series A warrants, but will receive funds from the exercise of the Series B warrants.
• The company intends to use the net proceeds from the exercise of the Series B warrants for working capital and general corporate purposes.
• The company's common shares are listed on NYSE American under the symbol EFSH, and the last reported sale price on February 12, 2025, was $0.187 per share.
• The selling shareholders may offer and sell the common shares in public or private transactions at fixed, market, related, or negotiated prices.
• The company is seeking shareholder approval for the issuance of shares upon exercise of warrants and for certain exercise price resets.
• The company has agreed to file a registration statement to register the resale of the shares and use its best efforts to have it declared effective.
• Failure to meet certain deadlines related to the registration statement could result in the company paying liquidated damages to the purchasers.

Sentiment

Score: 4

Explanation: The sentiment is neutral to slightly negative. While the registration statement itself is a procedural step, the details of the offering, including the potential for dilution and the company's history of amending and extending promissory notes, raise concerns about the company's financial health.

Positives

• The company may receive up to approximately $22.8 million from the exercise of the Series B warrants, which can be used for working capital and general corporate purposes.
• The registration statement allows selling shareholders to offer their shares for resale, potentially increasing liquidity.
• The company has the flexibility to use the proceeds from the Series B warrants for various purposes, including acquisitions and investments.
• The company has filed the registration statement in a timely manner.

Negatives

• The company will not receive any proceeds from the sale of common shares by the selling shareholders or from the exercise of the pre-funded warrants or Series A warrants.
• The exercise prices of the Series A and Series B warrants can be significantly reduced based on certain events, which could dilute existing shareholders.
• The company may be required to pay liquidated damages if it fails to meet certain deadlines related to the registration statement.
• The company has a history of amending and extending promissory notes, indicating potential financial challenges.

Risks

• Investing in the company's securities involves a high degree of risk, and investors should be able to bear a complete loss of their investment.
• The company's ability to achieve its goals depends on its management and acquisition strategies.
• The company's business is subject to various risks and uncertainties, including those related to its industry, competition, and financial performance.
• The company's reliance on its manager, 1847 Partners LLC, and the potential for conflicts of interest.
• The potential for dilution of existing shareholders due to the issuance of shares upon exercise of warrants.
• The company's ability to obtain shareholder approval for the issuance of shares upon exercise of warrants and for certain exercise price resets.
• The company's ability to maintain compliance with NYSE American listing requirements.
• The company's ability to generate sufficient cash flow to meet its debt obligations.

Future Outlook

The company expects to use the net proceeds from the exercise of the Series B warrants for working capital and other general corporate purposes, and may also use a portion of the proceeds to acquire, license, or invest in complementary products, technologies, or businesses.

Industry Context

As an acquisition holding company, 1847 Holdings operates in a competitive market for acquiring and managing small businesses. The company's success depends on its ability to identify and acquire suitable businesses, manage them effectively, and generate returns for its shareholders.

Comparison to Industry Standards

• It's difficult to directly compare 1847 Holdings to industry standards without knowing the specific industries of its subsidiaries.
• However, as an acquisition holding company, its performance can be compared to other private equity firms and holding companies that focus on acquiring and managing small businesses.
• Key metrics for comparison would include return on invested capital, revenue growth, EBITDA margins, and cash flow generation.
• Some comparable companies might include firms like Berkshire Hathaway (though much larger), or other smaller private equity groups that consolidate smaller businesses.

Stakeholder Impact

• Shareholders may experience dilution if the warrants are exercised.
• Employees may be affected by the company's financial performance and strategic decisions.
• Customers may be affected by the company's ability to provide quality products and services.
• Suppliers may be affected by the company's ability to pay its bills on time.
• Creditors may be affected by the company's ability to meet its debt obligations.

Next Steps

• The company needs to obtain shareholder approval for the issuance of shares upon exercise of warrants and for certain exercise price resets.
• The company needs to file a registration statement to register the resale of the shares and use its best efforts to have it declared effective.
• The selling shareholders may offer and sell the common shares in public or private transactions.

Key Dates

Keywords

common shares, warrants, registration statement, selling shareholders, private placement, exercise price, shareholder approval, liquidated damages, EFSH, 1847 Holdings